Wednesday, May 03, 2017 2:06:16 PM
most of the commitment made to the FDA following that inspection
There are problems that will take a a lot of time to resolve.
I'm not sure but my best guess is that Pfizer had a CGMP section Titled : Don't Put Cardboard in a Vial in their Guidelines, yet for some reason cardboard got into a vial.
That's not a problem (sheet happens) but the real problem was that Pfizer not only didn't catch it but it also didn't deal with the situation on many fronts when it realized the problem such as recalls, notifications, product quarantine etc.
This is not a problem of writing another CGMP policy, it is a problem of implementing your current guidelines and there's no solution to that problem except execution over a given timeperiod. Pfizer lost the faith of the FDA and it will take many repeat visits to gain the trust back.
FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
